Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | GAL |
Upstream (Parents) |
---|
(<<) AKT3 → GAL |
(<<) CASP7 → GAL |
(<<) CIRH1A → GAL |
(<<) DDX18 → GAL |
(<<) ENTPD7 → GAL |
(<<) HOPX → GAL |
(<<) MREG → GAL |
(<<) MYC → GAL |
(<<) PFDN2 → GAL |
(<<) PPIF → GAL |
(<<) PRKX → GAL |
(<<) RECK → GAL |
(<<) RORA → GAL |
(<<) RRP9 → GAL |
(<<) SEH1L → GAL |
(<<) SFXN4 → GAL |
(<<) SRC → GAL |
(<<) THOC4 → GAL |
(<<) TUBA1A → GAL |
(<<) UBE2C → GAL |
Downstream (Children) |
---|
GAL → ATAD3C (>>) |
GAL → CD3EAP (>>) |
GAL → DDX21 (>>) |
GAL → E2F5 (>>) |
GAL → EIF4EBP1 (>>) |
GAL → FERMT1 (>>) |
GAL → IGFBP3 (>>) |
GAL → LYAR (>>) |
GAL → MAP2K3 (>>) |
GAL → NOS3 (>>) |
GAL → ODC1 (>>) |
GAL → RAB7B (>>) |
GAL → STX12 (>>) |